Merck KGaA (MKKGY)
OTCMKTS · Delayed Price · Currency is USD
25.02
-0.44 (-1.74%)
Sep 12, 2025, 3:58 PM EDT
Merck KGaA Employees
Merck KGaA had 59,020 employees as of December 31, 2024. The number of employees decreased by 3,888 or -6.18% compared to the previous year.
Employees
59,020
Change (1Y)
-3,888
Growth (1Y)
-6.18%
Revenue / Employee
$394,546
Profits / Employee
$53,235
Market Cap
54.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59,020 | -3,888 | -6.18% |
Dec 31, 2023 | 62,908 | -1,324 | -2.06% |
Dec 31, 2022 | 64,232 | 3,898 | 6.46% |
Dec 31, 2021 | 60,334 | 2,207 | 3.80% |
Dec 31, 2020 | 58,127 | 1,056 | 1.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Merck KGaA News
- 4 days ago - Merck Foundation CEO Meets the First Lady of Cabo Verde & 13 African and Asian First Ladies of Africa at the Merck Foundation First Ladies Initiative Summit 2025 - Business Upturn
- 8 days ago - Merck Foundation CEO Meets Zimbabwe First Lady & 13 First Ladies of Africa and Asia at the 7th Edition of Merck Foundation First Ladies Initiative Summit to Discuss the Strategy to Build Healthcare Capacity and Support Girl Education - Business Upturn
- 9 days ago - Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Financial Post
- 9 days ago - Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Business Wire
- 10 days ago - Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector - Business Wire
- 15 days ago - mRNA Biotechs - Long-Term Value Risks Abound - Seeking Alpha
- 5 weeks ago - Merck KGaA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Merck KGaA (MKGAF) Q2 2025 Earnings Call Transcript - Seeking Alpha